NEW YORK: Global healthcare company Johnson & Johnson plans to start a phase 3 clinical trial of its Covid-19 vaccine ahead of its original schedule, possibly in late September, a senior company executive said. Johnson & Johnson is in talks with the US National Institute of Health to begin the …
Read More »
Moderna’s shares rose as much as 18% on Wednesday after the company announced that an early test of the coronavirus vaccine produced antibodies in all participants. A dose range induced immune responses in all 45 patients in the phase 1 trial and was “generally safe and well tolerated,” Moderna said …
Read More »
WASHINGTON (AP) – The first COVID-19 vaccine tested in the US boosted people’s immune systems as scientists expected, the researchers reported Tuesday, as the vaccines are about to begin key final tests. . “No matter how this is cut, this is good news,” Dr. Anthony Fauci, the top infectious disease …
Read More »
An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in the production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results from a phase 1 trial published today. at New England Journal of Medicine. The experimental vaccine …
Read More »
(Newser) – The first COVID-19 vaccine tested in the US boosted people’s immune systems as scientists expected, the researchers reported Tuesday, as the vaccines are about to begin key final tests. “No matter how this is cut, this is good news,” Dr. Anthony Fauci, the government’s top infectious disease expert, …
Read More »